+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome

Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome

Journal of Korean Medical Science 31(1): 47-54

Gitelman's syndrome (GS) is caused by loss-of-function mutations in SLC12A3 and characterized by hypokalemic metabolic alkalosis, hypocalciuria, and hypomagnesemia. Long-term prognosis and the role of gene diagnosis in GS are still unclear. To investigate genotype-phenotype correlation in GS and Gitelman-like syndrome, we enrolled 34 patients who showed hypokalemic metabolic alkalosis without secondary causes. Mutation analysis of SLC12A3 and CLCNKB was performed. Thirty-one patients had mutations in SLC12A3, 5 patients in CLCNKB, and 2 patients in both genes. There was no significant difference between male and female in clinical manifestations at the time of presentation, except for early onset of symptoms in males and more profound hypokalemia in females. We identified 10 novel mutations in SLC12A3 and 4 in CLCNKB. Compared with those with CLCNKB mutations, patients with SLC12A3 mutations were characterized by more consistent hypocalciuria and hypomagnesemia. Patients with 2 mutant SLC12A3 alleles, compared with those with 1 mutant allele, did not have more severe clinical and laboratory findings except for lower plasma magnesium concentrations. Male and female patients did not differ in their requirement for electrolyte replacements. Two patients with concomitant SLC12A3 and CLCNKB mutations had early-onset severe symptoms and showed different response to treatment. Hypocalciuria and hypomagnesemia are useful markers in differentiation of GS and classical Bartter's syndrome. Gender, genotypes or the number of SLC12A3 mutant alleles cannot predict the severity of disease or response to treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 058366713

Download citation: RISBibTeXText

PMID: 26770037

DOI: 10.3346/jkms.2016.31.1.47

Related references

Digenetic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome. Bmc Pediatrics 19(1): 114, 2019

Novel SLC12A3 mutations in Chinese patients with Gitelman's syndrome. Nephron. Physiology 108(3): P29-P36, 2008

Identification of fifteen novel mutations in the SLC12A3 gene encoding the Na-Cl Co-transporter in Italian patients with Gitelman syndrome. Human Mutation 20(1): 78, 2002

Genetic Features of Chinese Patients with Gitelman Syndrome: Sixteen Novel SLC12A3 Mutations Identified in a New Cohort. American Journal of Nephrology 44(2): 113-121, 2017

Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatric Research 48(6): 754-758, 2000

Novel mutations in the SLC12A3 gene causing Gitelman's syndrome in Swedes. Dna Sequence 18(5): 395-399, 2007

A case report of Gitelman syndrome resulting from two novel mutations in SLC12A3 gene. Nefrologia 36(3): 304-309, 2017

Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome. Clinical Journal of the American Society of Nephrology 6(3): 630-639, 2011

Compound heterocygosis for intron 9 + 1 g > T and Leu850pro mutations in the SLC12A3 gene in Gitelman's syndrome. Nefrologia 28(6): 659-660, 2008

Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. Journal of the American Society of Nephrology 18(4): 1271-1283, 2007

Mixed Bartter-Gitelman syndrome: an inbred family with a heterogeneous phenotype expression of a novel variant in the CLCNKB gene. Springerplus 3: 96, 2014

Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome. Journal of the American Society of Nephrology 26(2): 271-279, 2015

Identification of two novel mutations in SLC12A3 gene in two Chinese pedigrees with Gitelman syndrome and review of literature. Clinical Endocrinology 83(6): 985-993, 2016

Analysis of mutations of two Gitelman syndrome family SLC12A3 genes and proposed treatments using Chinese medicine. Chinese Journal of Integrative Medicine 23(6): 461-468, 2016

Clinical and analytical findings in Gitelman's syndrome associated with homozygosity for the c.1925 G>A SLC12A3 mutation. American Journal of Nephrology 30(3): 218-221, 2010